The TransMedics Organ Care System for the liver receives FDA pre-market approval
- PMID: 34802155
- DOI: 10.1111/aor.14115
The TransMedics Organ Care System for the liver receives FDA pre-market approval
Abstract
The Federal Drug Administration grants pre-market approval to TransMedics Organ Care System Liver, a platform designed to prolong donor organ viability via ex vivo perfusion in preparation for transplant.
© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
References
FURTHER READING
-
- Senior M. Beating the organ clock. Nat Biotechnol. 2018;36:488-92.
-
- Markmann J, et al. Superior post-transplant clinical outcomes using portable normothermic perfusion and assessment with the organ care system (OCS) liver system: 1-year outcomes of the OCS liver protect randomized controlled trial. Am J Transplant. 2021;21.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
